Page last updated: 2024-10-27

fleroxacin and Pneumocystis Infections

fleroxacin has been researched along with Pneumocystis Infections in 1 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Pneumocystis Infections: Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia (PNEUMONIA, PNEUMOCYSTIS) and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fishman, JA1
Queener, SF1
Roth, RS1
Bartlett, MS1

Other Studies

1 other study available for fleroxacin and Pneumocystis Infections

ArticleYear
Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:7

    Topics: Animals; Disease Models, Animal; Fleroxacin; Mice; Mice, Inbred BALB C; Mice, SCID; Pneumocystis; Pn

1993